Author

Lisanne F. van Dessel

Erasmus MC

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetic & Genomic Medicine· 1 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:differential expression· 1 Assay:DNA methylation· 1 Approach:experimental assay· 1 Approach:machine learning (classical)· 1 Research Focus:variant calling· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

John W.M. MartensiD· 2 shared Martijn P. LolkemaiD· 2 shared Anouk C. de JongiD· 1 shared Chris J. de WitteiD· 1 shared Christina Stangl· 1 shared Cornelis Verhoef· 1 shared Dirk Jan GrünhageniD· 1 shared Ivo Renkens· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

John W.M. MartensORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsClinical EpigeneticsPeer-reviewedOct 20, 2021

High throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by Methylated DNA sequencing (MeD-seq) of LpnPI digested fragments

Teoman Deger, Ruben Boers, Vanja de Weerd…·Saskia M. Wilting

This paper validates MeD-seq for cfDNA methylation profiling in cancer patients, showing distinct pre-surgical methylation patterns compared to healthy donors.

29 citations

humanDNA methylation

𝕏 PostBluesky

Genetic & Genomic MedicineGenome MedicinePeer-reviewedMay 18, 2021

Rapid identification of genomic structural variations with nanopore sequencing enables blood-based cancer monitoring

Jose Espejo Valle-Inclán, Christina Stangl, Anouk C. de Jong…·Wigard P. Kloosterman

SHARC rapidly identifies somatic genomic structural variations from nanopore sequencing for blood-based cancer monitoring, detecting ten SVs per sample and enabling treatment response tracking in metastatic prostate cancer.

46 citationstop 4%

humanwhole-genome sequencing

𝕏 PostBluesky